Image For Activity Cover
DDW 2018 Presidential Plenary Debate: Dr. Prateek Sharma v Dr. Marcia Irene Canto | August 2018
Description
Barrett’s esophagus is the presence of specialized intestinal metaplasia of the tubular esophagus and is recognized as a precursor lesion to esophageal adenocarcinoma. The development of Barrett’s esophagus is believed to be a reparative response to reflux-induced damage to the native squamous epithelium, with subsequent replacement with a metaplastic intestestinalized epithelium. Metaplastic Barrett’s esophagus is associated with increased cellular proliferation and turnover that may result in progression to dysplasia. This session assesses ablative techniques that are considered in balancing effective elimination of all dysplastic mucosa with the possibility of damaging deeper esophageal layers.

Is RFA the “King” in complete eradication of Barrett’s Esophagus? Should cryotherapy be considered as the technique where it causes cellular destruction by using freeze-thaw cycles?

Listen to the experts, Dr. Prateek Sharma and Dr. Marcia Irene Canto, debate the pros and cons associated with considering the use of these techniques
Authors
Dr. Prateek Sharma
Dr. Marcia Irene Canto
Hardware/Software Requirements
Windows Requirements:
Operating system: Windows 7+
Browser: Internet Explorer 8+, Firefox 10+, Google Chrome 10+
Internet connection: DSL, cable modem, or other high-speed connection
Flash: Adobe® Flash® Player 12+

Macintosh Requirements:
Operating system: Mac OS X 10.6.8+
Browser: Mozilla Firefox 10+, Safari 5+, Google Chrome 10+
Internet connection: DSL, cable modem, or other high-speed connection
Flash: Adobe® Flash® Player 12+
Contact Information
For technical difficulties, please contact ASGE between the hours of 8:30am and 5pm Central Time at 1-866-353-ASGE (2743). For questions related to content or CME credits, please email education@asge.org
Summary
Availability: On-Demand
Available Aug 01, 2018 to Aug 01, 2021
Cost: Member: $0.00
Non-Member: $30.00
Credit Offered: 0.25 CME Credit
0.25 Participation Credit
Recommended
Powered By